Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

Nature Genetics - Tập 41 Số 2 - Trang 192-198 - 2009
Minerva M. Carrasquillo1, Fanggeng Zou1, V. Shane Pankratz2, Samantha L. Wilcox1, L i1, Louise Walker1, Samuel Younkin1, Curtis Younkin1, Linda H. Younkin1, Gina Bisceglio1, Nilüfer Ertekin‐Taner1, Julia E. Crook3, Dennis W. Dickson1, Ronald C. Petersen4, Neill R. Graff‐Radford4, Steven T. DeKosky1
1Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, 32224, Florida, USA
2Division of Biomedical Statistics and Informatics, Mayo Clinic and Mayo Foundation, Rochester, 55905, Minnesota, USA
3Biostatistics Unit, Mayo Clinic College of Medicine, Rochester, 55905, Minnesota, USA
4Department of Neurology, Mayo Clinic College of Medicine, Rochester, 55905, Minnesota, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Evans, D.A. et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. J. Am. Med. Assoc. 262, 2551–2556 (1989).

Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923 (1993).

Corder, E.H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180–184 (1994).

Farrer, L.A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278, 1349–1356 (1997).

Gatz, M. et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63, 168–174 (2006).

Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

Williams, N.A., Close, J.P., Giouzeli, M. & Crow, T.J. Accelerated evolution of protocadherin11X/Y: a candidate gene-pair for cerebral asymmetry and language. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 623–633 (2006).

Lopes, A.M. et al. Inactivation status of PCDH11X: sexual dimorphisms in gene expression levels in brain. Hum. Genet. 119, 267–275 (2006).

Durand, C.M. et al. Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 67–70 (2006).

Blanco, P., Sargent, C.A., Boucher, C.A., Mitchell, M. & Affara, N.A. Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. Mamm. Genome 11, 906–914 (2000).

Blanco-Arias, P., Sargent, C.A. & Affara, N.A., Protocadherin X (PCDHX) and Y (PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains. Mamm. Genome 15, 41–52 (2004).

Senzaki, K., Ogawa, M. & Yagi, T. Proteins of the CNR family are multiple receptors for Reelin. Cell 99, 635–647 (1999).

Haas, I.G., Frank, M., Veron, N. & Kemler, R. Presenilin-dependent processing and nuclear function of gamma-protocadherins. J. Biol. Chem. 280, 9313–9319 (2005).

Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).